Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...
Andrew Spaventa, the Chief Executive Officer of Singular Genomics Systems , Inc. (NASDAQ:OMIC), recently sold 800 shares of the company's common stock, totaling $15,912. The shares were sold at an ...
Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...
Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...
Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered price targets amid profitability concerns.
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...
PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results ...
Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...
Dante Genomics, a global leader in AI-driven genomic analysis, has expanded into Dante Omics AI to reflect its evolution into ...
CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M ...
PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Wednesday reported a loss of $49 million in its fourth quarter. The Pleasanton, California-based company said it had ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback